Prescription drug · ANDA
prucalopride NDC 72578-221
Prucalopride succinate 1 mg/1 · Tablet, Film coated · Oral · Viona Pharmaceuticals Inc
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 72578-221-06 | 72578022106 | 30 TABLET, FILM COATED in 1 BOTTLE (72578-221-06)Marketed from Feb 2, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- prucalopride
- Generic name (nonproprietary)
- prucalopride
- Active ingredients
- Prucalopride succinate — 1 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Viona Pharmaceuticals Inc
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 218056
- Marketing start
- Listing expires
- Other FDA classes
- Serotonin 4 Receptor Agonists (Mechanism)
- Identifiers
- Product ID 72578-221_6d8aeb40-9dce-4be0-897e-87ad2c5d828eSPL ID 6d8aeb40-9dce-4be0-897e-87ad2c5d828eSPL set ID af559917-802b-486c-9f7b-b770115acac8RxCUI 2107345, 2107353UNII 4V2G75E1CK
- Pharmacologic class
- Serotonin-4 Receptor Agonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N472578022106followed by a unit qualifier and the quantityPackage 72578-0221-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Prucalopride tablets are indicated for the treatment of chronic idiopathic constipation (CIC) in adults. Prucalopride tablet is a serotonin-4 (5-HT 4 ) receptor agonist indicated for the treatment of chronic idiopathic constipation (CIC) in adults. ( 1 )
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 218056
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| prucalopride | Prucalopride succinate 2 mg/1 | Tablet, Film coatedOral | Zydus Lifesciences Limited | 70771-1900 |
| prucalopride | Prucalopride succinate 1 mg/1 | Tablet, Film coatedOral | Zydus Lifesciences Limited | 70771-1899 |
| prucalopride | Prucalopride succinate 2 mg/1 | Tablet, Film coatedOral | Viona Pharmaceuticals Inc | 72578-222 |